BTIG Upgrades Medtronic to Buy, Announces $90 Price Target

Benzinga Newsdesk www.benzinga.com Positive 77.2%

Neg 0% Neu 0% Pos 77.2%

BTIG analyst Ryan Zimmerman upgrades Medtronic (NYSE:MDT) from Neutral to Buy and announces $90 price target.

Comments

No comments yet. Be the first!